Literature DB >> 25952691

Comorbidities and Risk of Complications After Surgery for Esophageal Cancer: A Nationwide Cohort Study in Sweden.

Lovisa Backemar1, Pernilla Lagergren, Therese Djärv, Asif Johar, Anna Wikman, Jesper Lagergren.   

Abstract

BACKGROUND: The selection for surgery is multifaceted for patients diagnosed with esophageal cancer. Since it is uncertain how comorbidity should influence the selection, this study addressed comorbidities in relation to risk of severe complications following esophageal cancer surgery.
METHODS: This population-based cohort study was based on prospectively included patients who underwent surgical resection for an esophageal or gastro-esophageal junctional cancer in Sweden during 2001-2005. The participation rate was 90%. Associations between pre-defined comorbidities and pre-defined post-operative complications occurring within 30 days of surgery were analyzed using multivariable logistic regression. The resulting odds ratios (ORs) and 95% confidence intervals (CIs) were adjusted for age, sex, tumor stage, tumor histology, neoadjuvant therapy, type of surgery, annual hospital volume, other comorbidities, and other complications.
RESULTS: Among 609 included patients, those with cardiac disease (n = 92) experienced an increased risk of pre-defined complications in general (adjusted OR 1.81, 95% CI 1.13-2.90), while patients with hypertension (n = 137), pulmonary disorders (n = 79), diabetes (n = 67), and obesity (n = 66) did not. Patients with a Charlson comorbidity index score ≥2 had substantially increased risks of pre-defined complications (adjusted OR 2.44, 95% CI 1.60-3.72).
CONCLUSION: Cardiac disease and a Charlson comorbidity index score ≥2 seem to increase the risk of severe and early post-operative complications in patients with esophageal cancer, while hypertension, pulmonary disorders, diabetes, and obesity do not. These findings should be considered in the clinical decision-making for improved selection of patients for surgery.

Entities:  

Mesh:

Year:  2015        PMID: 25952691     DOI: 10.1007/s00268-015-3093-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

1.  Outcomes after esophagectomy: a ten-year prospective cohort.

Authors:  Stephen H Bailey; David A Bull; David H Harpole; Jeffrey J Rentz; Leigh A Neumayer; Theodore N Pappas; Jennifer Daley; William G Henderson; Barbara Krasnicka; Shukri F Khuri
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

2.  Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden.

Authors:  Pernilla Viklund; Mats Lindblad; Ming Lu; Weimin Ye; Jan Johansson; Jesper Lagergren
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Authors:  Hude Quan; Bing Li; Chantal M Couris; Kiyohide Fushimi; Patrick Graham; Phil Hider; Jean-Marie Januel; Vijaya Sundararajan
Journal:  Am J Epidemiol       Date:  2011-02-17       Impact factor: 4.897

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Analysis of reduced death and complication rates after esophageal resection.

Authors:  B P Whooley; S Law; S C Murthy; A Alexandrou; J Wong
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

6.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

7.  Atrial fibrillation after surgery for esophageal carcinoma: clinical and prognostic significance.

Authors:  Jian-Yang Ma; Yun Wang; Yong-Fan Zhao; Zhu Wu; Lun-Xu Liu; Ying-Li Kou; Jun-Jie Yang
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

Review 8.  Reducing hospital morbidity and mortality following esophagectomy.

Authors:  B Zane Atkins; Ashish S Shah; Kelley A Hutcheson; Jennifer H Mangum; Theodore N Pappas; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

9.  Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model.

Authors:  Cameron D Wright; John C Kucharczuk; Sean M O'Brien; Joshua D Grab; Mark S Allen
Journal:  J Thorac Cardiovasc Surg       Date:  2009-03       Impact factor: 5.209

10.  External review and validation of the Swedish national inpatient register.

Authors:  Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

View more
  10 in total

1.  Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization.

Authors:  Silvio Däster; Savas D Soysal; Luca Koechlin; Lea Stoll; Ralph Peterli; Markus von Flüe; Christoph Ackermann
Journal:  Langenbecks Arch Surg       Date:  2016-07-19       Impact factor: 3.445

2.  The resistance of esophageal cancer cells to paclitaxel can be reduced by the knockdown of long noncoding RNA DDX11-AS1 through TAF1/TOP2A inhibition.

Authors:  Shuyao Zhang; Hong Jiang; Zhe Xu; Yi Jiang; Yuqi She; Xiaoting Huang; Shanna Feng; Wanying Chen; Shuang Chen; Yun Chen; Guodong Qiu; Shilong Zhong
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

3.  Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer.

Authors:  Noriyuki Hirahara; Takeshi Matsubara; Shunsuke Kaji; Hikota Hayashi; Koki Kawakami; Yohei Sasaki; Satoshi Takao; Natsuko Takao; Ryoji Hyakudomi; Tetsu Yamamoto; Yoshitsugu Tajima
Journal:  BMC Cancer       Date:  2022-06-30       Impact factor: 4.638

4.  The impact of the Charlson comorbidity index on the prognosis of esophageal cancer patients who underwent esophagectomy with curative intent.

Authors:  Kotaro Yamashita; Masayuki Watanabe; Shinji Mine; Ian Fukudome; Akihiko Okamura; Masami Yuda; Masaru Hayami; Yu Imamura
Journal:  Surg Today       Date:  2018-01-30       Impact factor: 2.549

5.  Accuracy of co-morbidity data in patients undergoing abdominal wall hernia repair: a retrospective study.

Authors:  S Hajibandeh; S Hajibandeh; R Deering; D McEleney; J Guirguis; S Dix; A Sreh; E Toner; A El Muntasar; A Kausar; G Sheikh; D OShea; A Shafiq; A Kelly; A Khan; D Arumugam; A Evans
Journal:  Hernia       Date:  2017-12-14       Impact factor: 4.739

6.  Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan.

Authors:  Wen-Chi Chou; Pei-Hung Chang; Chang-Hsien Lu; Keng-Hao Liu; Yu-Shin Hung; Chia-Yen Hung; Chien-Ting Liu; Kun-Yun Yeh; Yung-Chang Lin; Ta-Sen Yeh
Journal:  J Cancer       Date:  2016-04-28       Impact factor: 4.207

7.  Risk factors for postoperative complications in total thyroidectomy: A retrospective, risk-adjusted analysis from the National Surgical Quality Improvement Program.

Authors:  Lisa Caulley; Stephanie Johnson-Obaseki; Lindy Luo; Hedyeh Javidnia
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

8.  Impact of co-morbidity on reoperation or death within 90 days of surgery for oesophageal cancer.

Authors:  Z Cheng; A Johar; E Gottlieb-Vedi; M Nilsson; J Lagergren; P Lagergren
Journal:  BJS Open       Date:  2021-01-08

9.  Comparison of risk-scoring systems in the prediction of outcome after liver resection.

Authors:  S Ulyett; G Shahtahmassebi; S Aroori; M J Bowles; C D Briggs; M G Wiggans; G Minto; D A Stell
Journal:  Perioper Med (Lond)       Date:  2017-11-25

10.  [Prognostic Risk Factors for Patients Receiving Airway Stent Placement].

Authors:  Yuequn Niu; Sha Huang; Zhou An; Jie Tang; Wang Lv; Jian Hu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.